Abstract 12926: The Impact of Thoracic Aortic Aneurysm versus Dissection on Postoperative Outcomes After Thoracic Endovascular Aortic Repair

医学 动脉瘤 动脉瘤 主动脉瘤 外科 主动脉修补术 腔内修复术 冲程(发动机) 截瘫 心脏病学 解剖(医学) 内科学 腹主动脉瘤 工程类 脊髓 精神科 机械工程
作者
James A. Brown,Derek Serna‐Gallegos,Edgar Aranda‐Michel,Sarah Yousef,Yisi Wang,Forozan Navid,Courtenay Dunn‐Lewis,Ibrahim A Sultan
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:144 (Suppl_1)
标识
DOI:10.1161/circ.144.suppl_1.12926
摘要

Introduction: As thoracic endovascular aortic repair (TEVAR) is the standard of care for complicated Type B aortic dissection (TBAD) and descending thoracic aortic (DTA) aneurysm, it is critical to understand its outcomes and utilization. Hypothesis: Nationwide postoperative complications, admission costs, and 30- and 90-day readmissions after TEVAR are between TBAD and aneurysm. Methods: Codes from the International Classification of Diseases (ICD) 9 and 10 identified patients with a primary procedure code for TEVAR from 2010-2017 in the Nationwide Readmissions Database (with trend weights to generate national estimates). After ICD codes identified patients with thoracic or thoracoabdominal aortic dissection as well as aortic aneurysm, the two groups were compared. Mixed model logistic regression identified variables associated with readmission, treating individual hospital as a random effect. Results: An estimated 6594 patients underwent non-elective TEVAR, of which 4649 (70.5%) had TBAD and 1945 (29.5%) had aneurysm of the DTA. Patients with aneurysms were more likely to be older, be women, have cardiovascular disease, and have chronic pulmonary disease than patients with TBAD. In-hospital mortality was lower for aneurysm (5.7% vs. 10.9%, p<0.001) than TBAD. For patients with aneurysm, there was less stroke (4.6% vs. 7.1%), paraplegia (2.2% vs. 3.9%), acute kidney injury (18.2% vs. 34.5%), and mesenteric ischemia (2.0% vs. 5.8%) than TBAD. Patients with aneurysm had lower total cost of care during their index admission (48.0 vs. 65.2 x $1000) than TBAD. The proportion of 30-day and 90-day readmissions were similar across each group, with overall 30-day readmission being 23.6%, while 90-day readmission was 38.2%. On multivariable adjustment, aneurysm was not associated with increased odds of 30-day readmission (OR 1.02, 95% CI: 0.84, 1.25, p=0.820) or 90-day readmission (OR 0.97, 95% CI: 0.80, 1.19, p=0.780) compared to TBAD. Conclusions: While TBAD was associated with worse in-hospital mortality and higher incidence of complications, aortic disease was not associated with an increased odds of readmission through 90 days. However, the incidence of early readmission was substantial for patients undergoing non-elective TEVAR.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
qianci2009完成签到,获得积分10
1秒前
沟通亿心完成签到,获得积分10
2秒前
4秒前
qq完成签到 ,获得积分10
14秒前
陈永伟完成签到,获得积分10
18秒前
小许同学完成签到 ,获得积分10
22秒前
Ruuo616完成签到 ,获得积分10
23秒前
少川完成签到 ,获得积分10
24秒前
taozidetao完成签到 ,获得积分10
29秒前
Xiaojiu完成签到 ,获得积分10
30秒前
CQ完成签到 ,获得积分10
37秒前
三三完成签到,获得积分10
44秒前
愉快的犀牛完成签到 ,获得积分10
46秒前
川藏客完成签到 ,获得积分10
47秒前
56秒前
Steven发布了新的文献求助10
1分钟前
smz完成签到 ,获得积分10
1分钟前
抹茶小汤圆完成签到 ,获得积分10
1分钟前
1分钟前
xiaopan9083发布了新的文献求助10
1分钟前
ccc完成签到 ,获得积分10
1分钟前
1分钟前
淘宝叮咚完成签到,获得积分10
1分钟前
科研通AI2S应助科研通管家采纳,获得30
1分钟前
余味应助科研通管家采纳,获得10
1分钟前
科研通AI5应助xiaopan9083采纳,获得30
1分钟前
YifanWang应助Steven采纳,获得30
1分钟前
1分钟前
回首不再是少年完成签到,获得积分0
1分钟前
草莓熊1215完成签到 ,获得积分10
2分钟前
贰鸟完成签到,获得积分0
2分钟前
2分钟前
夜倾心完成签到,获得积分10
2分钟前
2分钟前
Shabby0-0发布了新的文献求助10
2分钟前
dddd完成签到 ,获得积分10
2分钟前
Shabby0-0完成签到,获得积分10
2分钟前
大模型应助墨月白采纳,获得10
2分钟前
风趣的芝麻完成签到 ,获得积分10
2分钟前
2分钟前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
Continuum Thermodynamics and Material Modelling 2000
Encyclopedia of Geology (2nd Edition) 2000
105th Edition CRC Handbook of Chemistry and Physics 1600
Maneuvering of a Damaged Navy Combatant 650
Периодизация спортивной тренировки. Общая теория и её практическое применение 310
Mixing the elements of mass customisation 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3779230
求助须知:如何正确求助?哪些是违规求助? 3324802
关于积分的说明 10219978
捐赠科研通 3039925
什么是DOI,文献DOI怎么找? 1668517
邀请新用户注册赠送积分活动 798703
科研通“疑难数据库(出版商)”最低求助积分说明 758503